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Cellular mechanisms for bi-directional regulation of tubular sodium
reabsorption. The molecular mechanisms underlying the regulation of
sodium excretion are incompletely known. Here we propose a general
model for a bi-direetional control of tubular sodium transporters by
natriuretic and antinatriuretie factors. The model is based on experimental
data from studies on the regulation of the activity of Na,K-ATPase, the
enzyme that provides the eleetroehemieal gradient necessary for tubular
reabsorption of electrolytes and solutes in all tubular segments. Regula-
tion is carried out to a large extent by autoerine and paraerine factors. Of
particular interest are the two eateeholamines, dopamine and norepineph-
rine. Dopamine is produced in proximal tubular cells and inhibits
Na4 ,K-ATPase activity in several tubule segments. Renal dopamine
availability is regulated by the degrading enzyme, eateehol-O-methyl
transferase. Renal sympathetic nerve endings contain norepinephrine and
neuropeptide Y (NPY). Activation of cs-adrenergie receptors increase and
activation of f3-adrenergie receptors decrease Na,KtATPase activity.
a-Adrenergie stimulation increases the Na affinity of the enzyme and
thereby the driving force for transeellular Na transport. Nfl' acts as a
master hormone by synergizing the a- and antagonizing the p-adrenergie
effects. Dopamine and norepioephrine control NatKtATPase activity
by exerting opposing forces on a common intracellular signaling system of
second messengers, protein kinases and protein phosphatases, ultimately
determining the phosphorylation state of Na,KtATPase and thereby its
activity. Important crossroads in this network are localized and function-
ally defined. Phosphorylation sites for protein kinase A and C have been
identified and their functional significance has been verified.
Homer Smith first brought attention to the importance of
understanding the principles that govern the regulation of tubular
Na transport, the main determinant of salt balance. Sodium
homeostasis is maintained with an amazing precision despite large
fluctuations in the daily salt intake. The vectorial transport of
sodium across the tubular cells by apical Na transporters and
basolaterally located Na,K-ATPase determines the rate of
tubular sodium reabsorption, and is governed by natriuretic and
antinatriuretic hormones (Fig. 1). Long-term regulation, medi-
ated by steroids and thyroid hormone, involves de novo synthesis
of NC transporters by alterations in their transcription rate.
Short-term regulation, for example, that exerted by cathecol-
amines and peptide hormones, includes alterations in the activity
of existing tubular Na + transporters. Reversible protein phos-
phorylation is one common and important mechanism by which
these latter factors carry out their regulatory function. A target
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protein is phosphorylated by kinases on specific phosphorylation
sites and dephosphorylated by phosphatases. These reactions
result in conformational changes and thereby alterations in activ-
ity of the modified proteins. The phosphorylation process is
regulated by second messengers, such as cAMP and Ca2 , which
in their turn are under hormonal control. NC,K-ATPase is the
most extensively studied NC transporter with regards to hor-
monal regulation, as well as phosphorylation-dephosphorylation.
We propose a general model for the bi-direetional control of NC
transporters by natriuretic and antinatriuretie hormones. Al-
though this model is mainly based on experimental data from our
studies on the regulation of NC,K-ATPase activity in the
proximal tubule (PCT) and the thick ascending limb of Henle
(mTAL), it should be applicable to most tubular NC transport-
ers.
Bi-directional regulation of NC transport by intrarenal
catecholamines and peptide hormones
The first evidence that renal NC,K-ATPase was a target
molecule for peptide hormones was obtained in 1987 [1], when it
was reported that dopamine inhibits the activity of proximal
tubular NC,K'-ATPase. Since then, the short-term regulation of
tubular Na,K'-ATPase by hormones has been extensively stud-
ied. Agents with a well-established natriuretic effect, such as
dopamine, ANF [2], parathyroid hormone [3], endothelin [4], and
PGE2 [5] inhibit the activity of NC,K-ATPase, while agents
with antinatriuretic effect such as norepinephrine, activating a-ad-
renergic receptors [6, 7], insulin [8] and angiotensin, in low doses
[2], stimulate the enzyme activity. This bi-directional regulation of
NC,KtATPase activity by catecholamines [7] implies that tubu-
lar NC reabsorption is modulated by the intrinsic balance
between the intrarenally produced dopamine and the adrenergic
tonus.
Dopamine
High salt diet induces natriuresis and increases renal dopamine
excretion. Intrarenally produced dopamine has a well-docu-
mented natriuretic effect and infusion of dopaminc antagonists
decrease sodium excretion. Dopamine is locally produced in
proximal tubular cells [reviewed in 9, 10]. The dopamine precur-
sor, L-DOPA, enters the cells by a NC coupled transporter [11].
L-DOPA is converted to dopamine by aromatic acid decarboxyl-
ase (AADC), present in high concentrations in proximal tubular
cells (Fig. 2) [12]. It has been suggested that the L-DOPA uptake
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is controlled by changes in salt intake, but experimental evidence
for this view is lacking [11]. Under high salt diet, AADC activity
is increased twofold and inhibition of AADC activity attenuates
the high-salt induced natriuresis [13, 14]. It is, however, generally
agreed that this enzyme does not represent the rate-limiting step
for renal dopamine synthesis. Dopamine is metabolized by cate-
chol-O-methyl-transferase (COMT), abundantly expressed in re-
nal proximal tubules [15]. In ongoing studies, we have observed
that COMT inhibition has a pronounced natriuretic effect, accen-
tuated by high salt intake. Renal dopamine availability can be
regulated on different levels—synthesis, storage or metabolism—
and these mechanisms are currently under investigation.
Intrarenally formed dopamine can act in an autocrine and a
paracrine fashion on proximal and distal tubular cells. Dopamine
DA1 receptors have been identified in all tubular segments, while
DA2 receptors have been identified in cortex and inner medulla
[16]. The dopamine induced decrease of Na,K-ATPase activity
requires the activation of both DA1 and DA2 receptors in PCT
[17], but is achieved by activation of the DA1 receptor alone in the
mTAL and cortical collecting duct [18, 19].
Norepinephrine and the role of neuropeptide Y
Renal sympathetic nerve activation leads to Na retention,
which is abolished in the presence of a-adrenergic antagonists
[20]. Conversely, renal denervation leads to profound natriuresis
[21]. Both a and f3 adrenergic receptors are present in proximal
tubular cells [22, 231. Activation of a-adrenergic receptors, by
oxymetazoline, stimulates Na,K-ATPase activity [7], while ac-
tivation of -adrenergic receptors, by isoproterenol, inhibits
Na,K-ATPase activity [24]. Norepinephrine has no net effect
on Na,K-ATPase activity as a result of the combined activation
of a- and f3-adrenergic receptors [24].
NPY (neuropeptide Y) is a co-transmitter with norepinephrine
in renal nerve endings [25] and is released at high frequency
stimulation [26]. It induces a dose-dependent stimulation of
proximal tubule Na,K-ATPase activity [25]. In the presence of
a sub-threshhold dose of NPY, norepinephrine stimulates
Na,K-ATPase activity. This effect is achieved by the ability of
Tubular lumen
Fig. 2. Dopamine is produced in proximal tubule cells. L-DOPA is trans-
ported into the cells and converted to dopamine by L-amino-acid decar-
boxylase (AADC). Dopamine can exit the cells and act as an autocrine or
paracrine factor on proximal and distal tubule cells. Dopamine is metab-
olized by cathecolamine transferase (COMT), also present in proximal
tubule cells.
NPY to synergize the stimulatory a-adrenergic, and to antagonize
the inhibitory 3-adrenergic effect on Na,K-ATPase activity.
Thus, NPY acts as a master hormone in renal tubular cells by
determining the net effect of its co-localized transmitter, norepi-
nephrine. [24].
Cellular basis for hi-directional control of Na,KtATPase
The inhibitory effect of dopamine on Na,K-ATPase activity
is abolished in the presence of a-agonists and the stimulatory
effect of a-agonists is abolished by dopamine [7]. This raises the
question whether Na,K-ATPase activity is under the bi-direc-
tional control of natriuretic and antinatriuretic hormones exerting
opposing forces on a common intracellular signaling network.
This hypothesis was tested in a series of studies from our
laboratory performed in collaboration with Paul Greengard and
his group at Rockefeller University.
Dopamine receptors are coupled to several second messenger
systems, including the adenylate cyclase-cAMP-protein kinase A
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Fig. 1. Tubular Na reabsorption is regulated by natriuretic and antinatri-
uretic factors that alter the activity of Na,KtATPase and Na influx
transporters.
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Fig. 3. A model for regulation of Na
reabsorption by natriuretic factors such as
dopamine (DA), parathyroid hormone (PTH)
and antinatnuretic factor (ANF) and
antinatriuretic factors such as norepinephrine
(NE), angiotensin II (Ang II) and neuropeptideY
(NPY). Na,KtATPase is phosphorylated and
deactivated via phosphorylation by protein
kinase A, G (PKA/PKG) and/or protein kinase
C (PKC) and is dephosphotylated by protein
phosphatase-1 (PPI) and/or protein
phosphatase 2B (PP2B). Dopamine increases
intracellular cAMP, thereby activating PKA.
PKA phosphoiylates dopamine- and cAMP-
regulated protein (DARPP-32), which thereby
acts an an inhibitor of PP1, resulting in an
increased phosphorylation State of Na,K-
ATPase. cr-adrenergic agents, via 0-receptors,
increase intracellular Ca2, thereby activating
PP2B, which in turn dephosphorylates DARPP-
32 and/or Na,KtATPase, resulting in a
decreased phosphorylation state of Na,K-
ATPase.
(P1(A) pathway [18, 27]. In most segments DA1 receptors are
coupled to a stimulation of adenylate cyclase; in the PCT,
however, they appear to simultaneously increase cAMP and
activate phospholipase C2 [16], thereby activating both PKA and
protein kinase C (PKC). Activation of PKA starts a phosphory-
lation cascade that involves activation of the endogenous protein
phosphatase-i inhibitors, dopamine- and cAMP-regulated phos-
phoprotein (DARPP32) and Inhibitor-i. These phosphoproteins
are both present in the kidney [18] and phosphorylated
DARPP-32 inhibits Na,K-ATPase in mTAL [28]. a-agonists
increase intracellular Ca2 and activate the Ca2 dependent
protein phosphatase 2B, calcineurin [29]. Calcineurin dephosphor-
ylates and inactivates DARPP-32 and Inhibitor-i [30], and medi-
ates a-adrenergic stimulation of Na,K-ATPase in PCT [31].
The target for this phosphosylation cycle, protein phosphatase-1,
dephosphorylates and activates Na,K-ATPase [32]. Based on
these observations we have proposed a model for the bi-direc-
tional regulation of Na,K-ATPase. In support of this model, we
have found that not only dopamine, but also cAMP abolishes the
a-agonist induced stimulation of Na,K-ATPase activity [2].
This model has been extended to include the natriuretic
hormone ANF and its second messenger cGMP, which both
phosphorylate DARPP-32 [331 and inactivate Na,K-ATPase
[2], as well as the antinatriuretic factors angiotensin [2] and NPY,
which both increase intracellular Ca2 and activate calcineurin
(Fig. 3) [29].
Reversible protein phosphorylation is the ultimate step in
regulation of Na transporters
The Na,K-ATPase has been the most extensively studied
Na transporter with regard to phosphorylation-dephosphoryla-
tion, and can serve as an example of how these reactions can
modify the function of a transporter. In the a subunit of Na,K-
ATPase, phosphorylation sites for two different protein kinases
have been identified, and their functional significance has been
verified by site-directed mutagenesis [34].
A PKA phosphorylation site was demonstrated in a cytoplas-
matic ioop in the C-terminal end of the a subunit. This site is well
conserved between species and between the different a isoforms.
Phosphorylation of this site in the rat renal Na,K-ATPase leads
to a decreased rate of ATP hydrolysis [34, 35].
There are presumably two PKC phosphorylation sites that are
both located in the N-terminal. They are not as well conserved as
the PKA phosphoiylation site [34, 35]. The site that was identified
in the bufo marinus is present in many species, while the site in the
rat al subunit is absent in many species, including humans [36].
The PKC phosphorylation sites are located in the most charged
region of the Na,K-ATPase a subunit, which is of great
importance for regulation of the ion transport. Recent studies
from our laboratory have shown that PKC phosphorylation of the
rat Na,K-ATPase changes the equilibrium between the Na
binding El form of the enzyme and the K binding E2 form of the
enzyme [371. In ongoing studies, we have transfected COS cells
with either wild-type rat renal Na,K -ATPase al subunit or al
mutated at the PKC phosphorylation site. In the wild-type cells,
activation of PKC by PDBu leads to a reduced rate of ATP
hydrolysis and an increase in intracellular Na but not in the
mutant cells, demonstrating the importance of the PKC phosphor-
ylation for regulation of Na±,K*ATPase activity.
Phosphorylation of the Na,K-ATPase a subunit by PKC has
also been demonstrated in intact tissue, both in the renal cortex
[38, 39] and in the choroid plexus [40]. Activation of PKC by
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PDBu leads to inhibition of proximal tubular Na1,K-ATPase
activity [41]. Inactivation of protein phosphatase-1 by caliculin A
and 10- to 20-fold higher doses of okadaic acid also leads to
inhibition of proximal tubular Na ,K-ATPase activity and phos-
phorylation of the cs subunit in the renal cortex [42].
Many of the Na1 transporting proteins that are considered to
play a role for the reabsorption of Na have now been cloned and
contain several putative phosphorylation sites for the most com-
mon serine-treonine-protein kinases and phosphatases. The ma-
jor apical Na influx transporter, the Na/H exchanger, is
regulated by phosphorylation [43] and has been shown to be
bi-directionally regulated by catecholamines [44]. There is, there-
fore, good reason to believe that the here proposed model for
bi-directional hormonal regulation of Na,K-ATPase is a gen-
eral principle, applicable to several sodium transporters.
Summary and conclusion
In summary, we have demonstrated that Na,K-ATPase
activity is regulated by phosphorylation, and that an intricate
system of dephosphorylation and phosphorylation reactions is
mastered by hormones regulating Na balance. This elegant
network of intracellular interactions is the basis for the fine tuned
regulation of Na reabsorption necessary to maintain Na ho-
meostasis.
Reprint requests to Anita Aperia, M.D., Department of Woman and Child
Health, Pediatric Unit, St. Göran s Children s Hospital, Karolinska Institute,
11281 Stockholm, Sweden.
References
1. APERIA A, BERTORELLO A, SERI I: Dopamine causes inhibition of
Na-K-ATPase activity in rat proximal convoluted tubule segments.
Am J Physiol 252:F39—F45, 1987
2. APERIA A, HOLTBACK U, SYREN M-L, SVENSSON L-B, FRYCKSTEDT J,
GREENGARD P: Activation/deactivation of renal Na,K-ATPase: A
final common pathway for regulation of natriuresis. FASEB J 8:436—
439, 1994
3. RIBEIRO CP, MANDEL U: Parathyroid hormone inhibits proximal
tubule Na-K-ATPase activity. Am J Physiol 262:F209—F216, 1992
4. ZEIDEL ML, BRADY HR, K0NE BC, GULLANS SR, BRENNER BM:
Endothelin, a peptide inhibitor of Na,KtATPase in intact renal
tubular epithelial cells. Am J Physiol 257:C1101—C1107, 1989
5. JABS K, ZEIDEL ML, SILvA F: Prostaglandin E2 inhibits Na-K'-
ATPase activity in the inner medullary collecting duct. Am J Physiol
257:F424—F430, 1989
6. BEACH RE, SCHWAB SJ, BRAZY PC, DENNIS VW: Norepinephrine
increases Na-K-ATPase and solute transport in rabbit proximal
tubules. Am J Physiol 252:F215—F220, 1987
7. IBARRA F, APERIA A, SvENSSON L-B, EKLOF A-C, GREENGARD P:
Bidirectional regulation of Na,K-ATPase activity by dopamine and
an a-adrenergic agonist. Proc Nati Acad Sci USA 90:21—24, 1993
8. FERAILLE E, MARSY 5, CHEVAL L, BARLET-BAS C, KHADOURI C,
FAvRE H, DOUCET A: Sites of antinatriuretic action of insulin along
rat nephron. Am J Physiol 263:F175—F179, 1992
9. Misr B, APERIA A: Molecular mechanisms involved in catechol-
amine regulation of sodium transport. Semin Nephrol 13:41—49, 1993
10. APERIA AC: Regulation of sodium transport. Curr Opin Nephrol
Hypertens 4:416—420, 1995
11. HOLTBACK U, APERIA A, CELCI G: High salt alone does not influence
the kinetics of the Na -H1 antiporter. Acta Physiol Scand 148:55—61,
1993
12. MEISTER B, FRIED G, HOLGERT H, APERIA A, HOKFELT T: Ontogeny
of aromatic L-amino acid decarboxylase-containing tubule cells in rat
kidney. Kidney lot 42:617—623, 1992
13. HAYASHI M, YAMAJI Y, KITAJIMA W, SARUTA T: Aromatic L-amino
acid decarboxylase activity along the rat nephron. Am J Physiol
258:F28—F33, 1990
14. SERI I, KONE BC, GULLANS SR, APERIA A, BRENNER BM, BALLERMAN
BJ: Locally formed dopamine inhibits Na-K-ATPase activity in rat
renal cortical tubule cells. Am J Physiol 255:F666—F673, 1988
15. MEISTER B, BEAN AJ, APERIA A: Catechol-O-metyltransferase mRNA
in the kidney and its appearance during ontogeny. Kidney mt 44:726—
733, 1993
16. JOSE PA, RAYMOND JR, BATES MD, APERIA A, FELDER RA, CAREY
RM: The renal dopamine receptors. JAm Soc Nephrol 2:1265—1278,
1992
17. BERTORELLO A, APERIA A: Inhibition of proximal tubule Na-K-
ATPase activity requires simultaneous activation of DA1 and DA2
receptors. Am J Physiol 259:F924—F928, 1990
18. MEISTER B, FRYCKSTEDT J, SCHALLING M, CORTES R, HOKFELT T,
APERIA A, HEMMINGS HC JR, NAIRN AC, EHRLICH ME, GREENGARD
F: Dopamine- and cAMP-regulated phosphoprotein (DARPP-32)
and dopamine DA1 agonist-sensitive Na,K-ATPase in renal tubule
cells. Proc NatlAcad Sci USA 86:8068—8072, 1989
19. SATOH T, COHEN HT, KATZ Al: Intracellular signaling in the regula-
tion of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase
A2. J Clin Invest 89:1496—1500, 1992
20. DIBONA GF: Neuronal regulation of tubular sodium reabsorption and
renin secretion. Fed Proc 44:12816—12822, 1985
21. BELLO-REUSS E, COLINDRES RE, PASTORIZA-MUNOZ E, MUELER RA,
GOTTSCHALK CW: Effects of acute unilateral renal denervation in the
rat. J Clin Invest 56:208—217, 1975
22. INSEL PA, SNAVELY MD, HEAvELY DP, MUNZEL PA, POTENZA CL,
NORD EP: Radioligand binding and functional assays demonstrate
postsynaptic alpha2-receptors on proximal tubules of rat and rabit
kidney. J Cardiovasc Pharmacol 7:9—17, 1985
23. MEI5TER B, DAGERLIND A, NICHOLASE AP, HOKFELT T: Patterns of
messenger RNA expression for adrenergic receptor subtypes in rat
kidney. JPharmcolExp Ther 268:1605—1611, 1994
24. HOLTBACK U, FORBERG P, OHTOMO Y, OHNO 5, SAHLGREN B, APERIA
A: NPY synergizes a and antagonizes J3 adrenergic receptor activation
in rat proximal tubules. (submitted for publication)
25. OHTOMO Y, MEISTER B, HOKFELT T, APERIA A: Coexisting NPY and
NE synergistically regulate renal tubular Na,KtATPase activity.
Kidney mt 45:1606—1613, 1994
26. LUNDBERG JM, PERNOW J, LACROIX JS: Neuropeptide Y: sympathetic
cotransmitter and modulator? NIPS 4:13—17, 1989
27. FRYCKSTEDT J, Svasso L-B, LINDEN M, APERIA A: The effect of
dopamine on adenylate cyclase and Na,K-ATPase activity in the
developing rat renal cortical and medullary tubule cells. Pediatr Res
34:308—311, 1993
28. APERIA A, FRYCKSTEDT J, SVENSSON L-B, HEMMINGS HC JR, NAIRN
AC, GREENGARD P: Phosphorylated M 32,000 dopamine- and cAMP-
regulated phosphoprotein inhibits Na1,K-ATPase activity in renal
tubule cells. Proc Nati Acad Sci USA 88:2798—2801, 1991
29. OHTOMO Y, ONo 5, SAHLGREN B, APERIA A: Maturation of rat renal
tubular response to a-adrenergic agonists and neuropeptide Y (NPY).
A study on the regulation of Na,K-ATPase. Pediatr Res (in press)
30. HEMMINGS HC JR. GREENGARD F, LIM TUNG HY, COHEN F: DARPP-
32, a dopamine-regulated neuronal phosphoprotein, is a potent
inhibitor of protein phosphatase-1. Nature 3 10:503—508, 1984
31. APERIA A, IBARRA F, SvENssoN L-B, KLEE C, GREENGARD F:
Calcineurin mediates a-adrenergic stimulation of Na * ,K -ATPase
activity in renal tubule cells. Proc Nati Acad Sci USA 89:7394—7397,
1992
32. BERTORELLO AM, APERIA A, WALAAS SI, NAIRN AC, GREENGARD F:
Phosphorylation of the catalytic subunit of Nar, K*ATPase inhibits
the activity of the enzyme. Proc Nat! Acad Sci USA 88:11359—11362,
1991
33. HEMMINGS HC JR, NAIRN AC, GREENGARD P: DARPP-32, a dopa-
mine- and adenosine 3':S'-monophosphate-regulated neuronal phos-
phoprotein. II. Comparison of the kinetics of phosphorylation of
DARPP-32 and phosphatase inhibitor 1. J Biol Chem 259:14491—
14497, 1984
34. FISONE G, CHENG SX-J, NAIRN AC, CZERNIK AJ, HEMMINGS HC JR,
HOOG J-O, BERTORELLO AM, KAISER R, BERGMAN T, JORNVALI. H,
APERIA A, GREENGARD F: Identification of the phosphorylation site
Aperia et al: Regulation of tubular sodium transport 1747
for cAMP-dependent protein kinase on Na,K-ATPase and effects
of site-directed mutagenesis. J Biol Chem 269:9368—9373, 1994
35. BEGUIN P, BEGGAH AT, CHIBALIN AV, BURGENER-KAIRUZ P, JASSIER
F, MATHEWS PM, RosslER BC, GEERING K: Phosphorylation of the
Na,K-ATPase a-subunit by protein kinase A and C (PKC) in vitro and
in intact cells: Identification of a novel motif for PKC-mediated
phosphorylation. J Biol Chem 269:24437—24445, 1994
36. FESCHENKO MS, SWEADNER KJ: Structural basis species-specific dif-
ferences in the phosphoiylation of Na,K-ATPase by protein kinase C.
J Biol Chem 270:14072—14077, 1995
37. LOGVINENKO NS, FEDOSOVA N, ESMAN M, FIs0NE G, NAIRN AC,
GREENGARD P, APERIA A: Protein kinase C phosphorylation modifies
the E1-E2 transition of renal Na,K-ATPase. (abstract) Proc Ann
Meet Am Soc Nephrol, Orlando, 1994, p 293
38. MIDDLETON JM, KHAN WA, COLLINSWORTFI G, HANNUN YA, ME0-
FORD RM: Heterogeneity of protein kinase C-mediated rapid regula-
tion of Na/K-ATPase in kidney epithelial cells. J Biol Chem 268:
15958—15964, 1993
39. Li D-L, SVENSSON L-B, FIs0NE G, NAIRN AC, GREENGARD P, APERIA
A: Phosphoiylation of Na,K-ATPase in intact renal tissue by
protein phosphatase inhibitors and protein kinase C activation. (ab-
stract) Proc Ann Meet Am Soc Nephrol, Orlando, 1994, p 291
40. FI50NE 0, SNYDER G L, FRYCKSTEDT J, CAPLAN M J, APERIA A,
GREENGARD P: Na,K-ATPase in the choroid plexus. Regulation by
serotonin/protein kinase C pathway. JBiol Chem 270:2427—2430, 1995
41. BERTORELLO A, APERIA A: Na-K-ATPase is an effector protein for
protein kinase C in renal proximal tubule cells. Am J Physiol 256:
F370—F373, 1989
42. Li D, APERIA A, CELSI G, DA CRUZ E, SILVA EF, GREENGARD P,
MEISTER B: Protein phosphatase-1 in the kidney: evidence for a role
in the regulation of medullary Na-K-ATPase. Am J Physiol (in
press)
43. WEINMAN EJ, DUBINSKY WP, FISHER K, STEPLOCK D, DINU Q, CHANG
L, SHENOLIKAR S: Regulation of reconstituted renal Na/H ex-
changer by calcium-dependent protein kinases. J Membr Biol 103:237—
244, 1988
44. GESEK FA, SCHOOLWERTH AC: Hormonal interactions with the
proximal Na-H exchanger. Am J Physiol 258:F514—F521, 1990
